Jens Juul Holst

Jens Juul Holst

Professor


  1. 1999
  2. Published

    Advances in non-peptide glucagon receptor antagonist. / Madsen, P.; Knudsen, L.B.; Brand, C.L.; Holst, J.J.

    In: Curr. Pharm Design, No. 5, 1999, p. 683-691.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients. / Toft-Nielsen, M.B.; Madsbad, S.; Holst, J.J.

    In: Diabetes Care, No. 22, 1999, p. 1137-1143.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Diabetic Intestinal Growth Adaptation and glucagon-like peptide 2 (GLP-2) in the rat. Effect of dietary fibres. / Thulesen, J.; Hartmann, B.; Nielsen, C.; Holst, J.J.; Poulsen, S.S.

    In: Gut, No. 45, 1999, p. 672-678.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Differential effects of saturated and monounsaturated fat on postprandial lipaemia and GIP/GLP-1 response in healthy subjects. / Thomsen, C.; Rasmussen, O.; Lousen, T.; Hermansen, K.; Holst, J.J.

    In: Am. J. Clin. Nutri., No. 69, 1999, p. 1135-1143.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Energy intake and appetite is suppressed by glucagon-like peptide-1 (GLP-1) in obese men. / Näslund, E.; Barkeling, B.; King, N.; Gutniak, M.K.; Blundell, J.E.; Holst, J.J.; Rössner, S.; Hellström, P.M.

    In: International Journal of Obesity, No. 23, 1999, p. 304-311.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Fast acting nervous regulation of immunoglobulin A secretion from isolated perfused porcine ileum. / Schmidt, P.T.; Eriksen, L.; Loftager, M.; Rasmussen, T.N.; Holst, J.J.

    In: Gut, No. 45, 1999, p. 679-685.

    Research output: Contribution to journalJournal articleResearch

  8. Published

    Glucagon-like peptide-1 (GLP-1): An intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential. / Holst, J.J.

    In: Trends in Endocrinology and Metabolism, No. 10, 1999, p. 229-235.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Glucagon-like peptide-1 slows solid gastric emptying and inhibits insulin, glucagon and peptide YY release in humans. / Näslund, E.; Bogefors, J.; Skogar, S.; Grybäck, P.; Jacobsen, H.L.; Holst, J.J.; Helström, P.M.

    In: Am. J. Physiol., No. 277, 1999, p. 910-916.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Glucagon-like peptide-1 suppresses energy expenditure in obese humans. / Flint, A.; Raben, A.; Holst, Jens Juul; Astrup, A.

    International journal of obesity. ed. / J.-P. Després; I. Macdonald. 23. ed. European Association for the Study of Obesity, 1999. p. S35.

    Research output: Chapter in Book/Report/Conference proceedingArticle in proceedingsResearch

  11. Published

    Glucagon-like peptide-1(7-36)amide is transformed to glucagon-like peptide-1 (9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the intestinal L-cells. / Hansen, L.; Deacon, C.F.; Ørskov, C.; Holst, J.J.

    In: Endokrinologiya, No. 140, 1999, p. 5356-5363.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 Next

ID: 4207